Loading chart…
PRE-MARKET
Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients.
Anthem Biosciences Limited (ANTHEM) is listed on the NSE in the Healthcare sector, Biotechnology industry. The ANTHEM share price is ₹942.35 (+3.34% today), with a market capitalisation of ₹531B and a price-to-earnings (P/E) ratio of 87.1. MarketRipple tracks the ANTHEM investment thesis, the ripple-chain impact of market events on Anthem Biosciences Limited, and the Healthcare sector outlook.
Open
₹915.00
High
₹952.00
Low
₹914.95
Prev. Close
₹911.85
52W High
₹977.55
52W Low
₹579.15
Day range
₹914.95–₹952.00
52-week range
₹579.15–₹977.55
Volume
241K
P/E
87.1
ROE
20.4%
D/E
0.02
Margin
29.9%
Anthem Biosciences Limited (NSE: ANTHEM) is currently trading at ₹942.35 (+3.34%).
Anthem Biosciences Limited's market capitalization is ₹531B.
Anthem Biosciences Limited's price-to-earnings (P/E) ratio is 87.1.
Anthem Biosciences Limited operates in the Healthcare sector (Biotechnology).
Analyst consensus on Anthem Biosciences Limited currently reads strongly positive, based on 8 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.